Journal of Substance Abuse Treatment
Volume 34, Issue 1 , Pages 123-138 , January 2008

A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders

  • Robert E. Drake, M.D. Ph.D.

      Affiliations

    • Department of Psychiatry, Dartmouth Medical School, Lebanon, NH, USA
    • Corresponding Author InformationCorresponding author. Dartmouth Psychiatric Research Center, 2 Whipple Place, Lebanon, NH 03766, USA. Tel.: +1 603 448 0263.
    • ,
  • Erica L. O'Neal, M.D.

      Affiliations

    • Department of Psychiatry, Dartmouth Medical School, Lebanon, NH, USA
    • ,
  • Michael A. Wallach, Ph.D.

      Affiliations

    • Department of Psychology and Neuroscience, Duke University, Durham, NC, USA

Received 7 August 2006 ,Revised 22 December 2006 ,Accepted 2 January 2007.

References 

  1. Adams JR, Drake RE. Shared decision making and evidence-based practice. Community Mental Health Journal. 2006;42:87–105
  2. Aguilera R, Anderson A, Gabire E, Merlo M, Paredes T, Pastrana R. A clinical impact evaluation of integrated and disease specific substance abuse program models in Honduras. International Journal of Psychosocial Rehabilitations. 1999;3:97–167
  3. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: Author; 1994;
  4. Anderson A. Comparative impact evaluation of two therapeutic programs for mentally ill chemical abusers. International Journal Psychosocial Rehabilitation. 1999;4:11–26
  5. Aubrey T, Cousins B, LaFerriere D, Wexler A. Evaluation of concurrent disorders group treatment program: Outcome evaluation report. Ottawa, Ontario: Center for Research on Community Services Faculty of Social Sciences, University of Ottawa; 2003;
  6. Baker A, Bucci S, Lewin TJ, Kay-Lambkin F, Constable PM, Carr VJ. Cognitive–behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial. British Journal of Psychiatry. 2006;188:439–448
  7. Baker A, Lewin T, Reichler H, Clancy R, Carr VJ, Garrett R, et al. Evaluation of a motivational interview for substance use with psychiatric in-patient services. Addiction. 2002;97:1329–1337
  8. Baker A, Lewin T, Reichler H, Clancy R, Carr V, Garrett R, et al. Motivational interviewing among psychiatric in-patients with substance use disorders. Acta Psychiatrica Scandinavica. 2002;106:233–240
  9. Barrowclough C, Haddock G, Tarrier N, Lewis SW, Moring J, O'Brien R, et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry. 2001;158:1706–1713
  10. Bartels SJ, Drake RE. Residential treatment for dual diagnosis. Journal of Nervous and Mental Disease. 1996;184:379–381
  11. Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry. 2006;63:426–432
  12. Blankertz LE, Cnaan RA. Assessing the impact of two residential programs for dually diagnosed homeless individuals. Social Service Review. 1994;68:536–560
  13. Bond GR, McDonel EC, Miller LD, Pensec M. Assertive community treatment and reference groups: An evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosocial Rehabilitation Journal. 1991;15:31–43
  14. Broner N, Lattimore PK, Cowell AJ, Schlenger WE. Effects of diversion on adults with co-occurring mental illness and substance use: Outcomes from a national multi-site study. Behavioral Sciences and the Law. 2004;22:519–541
  15. Brooks AJ, Penn PE. Comparing treatments for dual diagnosis: Twelve-step and self-management and recovery training. American Journal of Drug and Alcohol Abuse. 2003;29:359–383
  16. Brunette MB, Noordsy DL, Buckley P, Green AI. Pharmacologic treatments for co-occurring substance use disorders in patients with schizophrenia: A research review. Journal of Dual Diagnosis. 2005;1:41–55
  17. Brunette MF, Drake RE, Woods M, Hartnett T. A comparison of long-term and short-term residential treatment programs for dual diagnosis patients. Psychiatric Services. 2001;52:526–528
  18. Brunette MF, Mueser KT, Drake RE. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders. Drug and Alcohol Review. 2004;23:471–481
  19. Burnam MA, Morton SC, McGlynn EA, Petersen LP, Stecher BM, Hayes C, et al. An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. Journal of Addictive Diseases. 1995;14:111–134
  20. Calsyn RJ, Yonker RD, Lemming MR, Morse GA, Klinkenberg WD. Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals. Criminal Behavior and Mental Health. 2005;15:236–248
  21. Carey K. Substance use reduction in the context of outpatient psychiatric treatment: A collaborative, motivational, harm reduction approach. Community Mental Health Journal. 1996;32:291–306
  22. Carmichael D, Tackett-Gibson M, Dell O. Texas dual diagnosis project evaluation report 1997–1998. College Station, TX: Texas A&M University, Public Policy Research Institute; 1998;
  23. Center for Substance Abuse Treatment . Substance abuse treatment for persons with co-occurring disorders. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2005;
  24. Chandler DW, Spicer G. Integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders. Community Mental Health Journal. 2006;42:405–425
  25. De Leon G, Sacks S, Staines G, McKendrick K. Modified therapeutic community for homeless mentally ill chemical abusers: Treatment outcomes. American Journal of Drug and Alcohol Abuse. 2000;26:461–480
  26. Deegan PE, Drake RE. Shared decision-making and medication management in the recovery process: From compliance to alliance. Psychiatric Services. 2006;57:1636–1639
  27. Drake RE, Essock SM, Shaner A, Carey KB, Minkoff K, Kola L, et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services. 2001;52:469–476
  28. Drake RE, McHugo GJ, Clark RE, Teague GB, Ackerson T, Xie H, et al. A clinical trial of assertive community treatment for patients with co-occurring severe mental illness and substance use disorder. American Journal of Orthopsychiatry. 1998;68:201–215
  29. Drake RE, McHugo GJ, Xie H, Fox L, Packard J, Helmstetter B. Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders. Schizophrenia Bulletin. 2006;32:464–473
  30. Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin. 1998;24:589–608
  31. Drake RE, Morrissey J, Mueser KT. The challenge of treating forensic dual diagnosis clients. Community Mental Health Journal. 2006;42:427–432
  32. Drake RE, Mueser KT, Brunette M, McHugo GJ. A review of treatments for people with severe mental illness and co-occurring substance use disorder. Psychiatric Rehabilitation Journal. 2004;27:360–374
  33. Drake RE, Rosenberg SD, Teague GB, Bartels BJ, Torrey WC. Fundamental principles of evidence-based medicine applied to mental health care. Psychiatric Clinics of North America. 2003;26:811–820
  34. Drake RE, Wallach MA. Mental patients' attitudes toward hospitalization: A neglected aspect of hospital tenure. American Journal of Psychiatry. 1988;145:29–34
  35. Drake RE, Wallach MA, Alverson HS, Mueser KT. Psychosocial aspects of substance abuse by clients with severe mental illness. Journal of Nervous and Mental Disease. 2002;190:100–106
  36. Drake RE, Wallach MA, McGovern MP. Future directions in preventing relapse to substance abuse among clients with severe mental illness. Psychiatric Services. 2005;56:1297–1302
  37. Drake RE, Xie H, McHugo GJ, Shumway M. Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorder. Biological Psychiatry. 2004;56:749–756
  38. Drake RE, Yovetich NA, Bebout RR, Harris M, McHugo GJ. Integrated treatment for dually diagnosed homeless adults. Journal of Nervous and Mental Disease. 1997;185:298–305
  39. Drebing CE, Van Ormer EA, Krebs C, Rosenheck R, Rounsaville B, Herz L, et al. The impact of enhanced incentives on vocational rehabilitation outcomes for dually diagnosed veterans. Journal of Applied Behavioral Analysis. 2005;38:359–372
  40. Edwards J, Elkins K, Hinton M, Harrigan SM, Donovan K, Athanasopoulos O, et al. Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatrica Scandinavica. 2006;114:109–117
  41. Epstein J, Barker P, Vorburger M, Murtha C. Serious mental illness and its co-occurrence with substance use, 2002. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2004;
  42. Essock S, Mueser KT, Drake RE, Covell N, McHugo GJ, Frisman L, et al. Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders. Psychiatric Services. 2006;57:185–196
  43. Godley SH, Hoewing-Roberson R, Godley MD. Final MISA report. Bloomington, IL: Lighthouse Institute; 1994;
  44. Graeber DA, Moyers TB, Griffiths C, Guajardo E, Tonigan S. A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Mental Health Journal. 2003;39:189–202
  45. Haddock G, Barrowclough C, Tarrier N, Moring J, O'Brien R, Schofield N, et al. Cognitive–behavioural therapy and motivational intervention for schizophrenia and substance misuse. British Journal of Psychiatry. 2003;183:418–426
  46. Hellerstein DJ, Rosenthal RN, Miner CR. A prospective study of integrated outpatient treatment for substance-abusing schizophrenic patients. American Journal on Addictions. 1995;4:33–42
  47. Helmus TC, Saules KK, Schoener EP, Roll JM. Reinforcement of counseling attendance and alcohol abstinence in a community-based dual-diagnosis treatment program: A feasibility study. Psychology of Addiction Behaviors. 2003;17:249–251
  48. Ho AP, Tsuang JW, Liberman RP, Wang R, Wilkins JN, Eckman TA, et al. Achieving effective treatment of patients with chronic psychotic illness and comorbid substance dependence. American Journal of Psychiatry. 1999;156:1765–1770
  49. Hulse GK, Tait RJ. Six-month outcomes associated with a brief alcohol intervention for adult in-patients with psychiatric disorders. Drug and Alcohol Review. 2002;21:105–112
  50. James W, Preston NJ, Koh G, Spencer C, Kisely SR, Castle DJ. A group intervention which assists patients with dual diagnosis reduce their drug use: A randomised controlled trial. Psychological Medicine. 2004;34:983–990
  51. Jerrell JM, Ridgely MS. Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease. 1995;183:566–576
  52. Jerrell JM, Ridgely MS. Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs. Psychiatric Services. 1999;50:109–112
  53. Kasprow WJ, Rosenheck R, Frisman L, DiLella D. Residential treatment for dually diagnosed homeless veterans: A comparison of program types. American Journal on Addictions. 1999;8:34–43
  54. Kavanagh DJ, Young R, White A, Saunders JB, Wallis J, Shocklewy N, et al. A brief motivational intervention for substance misuse in recent-onset psychosis. Drug and Alcohol Review. 2004;23:151–155
  55. Kay-Lambkin FJ, Baker AL, Lewin TJ. The ‘co-morbidity roundabout’: A framework to guide assessment and intervention strategies and engineer change among people with co-morbid problems. Drug and Alcohol Review. 2005;23:407–423
  56. Ledgerwood DM, Petry NM. Does contingency management affect motivation to change substance use?. Drug and Alcohol Dependence. 2006;83:65–72
  57. Lehman AF, Herron JD, Schwartz RP, Myers CP. Rehabilitation for adults with severe mental illness and substance use disorders. A clinical trial. Journal of Nervous and Mental Disease. 1993;181:86–90
  58. Mangrum LF, Spence RT, Lopez M. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders. Journal of Substance Abuse Treatment. 2006;30:79–84
  59. McGovern MP, Wrisley BR, Drake RE. Substance use disorder relapse and its prevention: Implications for persons with comorbid psychiatric disorders. Psychiatric Services. 2005;56:1270–1273
  60. McHugo GJ, Drake RE, Brunette MF, Xie H, Essock SM, Green AI. Methodological issues in research on interventions for co-occurring disorders. Schizophrenia Bulletin. 2006;32:655–665
  61. McHugo GJ, Drake RE, Burton HL, Ackerson TH. A scale for assessing the stage of substance abuse treatment in persons with severe mental illness. Journal of Nervous and Mental Disease. 1995;183:762–767
  62. McHugo GJ, Drake RE, Teague GB, Xie H. Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services. 1999;50:818–824
  63. McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association. 2000;284:1689–1695
  64. Miller WR, Rollnick S. Motivational interviewing: Preparing people for change. 2nd ed. New York: Guilford Press; 2002;
  65. Moggi F, Ouimette PC, Moos RH, Finney JW. Dual diagnosis patients in substance abuse treatment: Relationship of general coping and substance-specific coping to 1-year outcomes. Addiction. 1999;94:1805–1816
  66. Morse GA, Calsyn DA, Klinkenberg WD, Helminiak TW, Wolff N, Drake RE, et al. Treating homeless clients with severe mental illness and substance use disorders: Costs and outcomes. Community Mental Health Journal. 2006;42:377–404
  67. Mueser KT, Drake RE, Sigmon SC, Brunette M. Psychosocial interventions for adults with severe mental illnesses and co-occurring substance use disorders: A review of specific interventions. Journal of Dual Diagnosis. 2005;1:57–82
  68. Mueser KT, Noordsy DL, Drake RE, Fox M. Integrated treatment for dual disorders: A guide to effective practice. New York: The Guilford Press; 2003;
  69. Mueser KT, Rosenberg SD, Drake RE, Miles KM, Wolford G, Vidaver R, et al. Conduct disorder, antisocial personality disorder, and substance use disorders in schizophrenia and major affective disorders. Journal of Studies on Alcohol. 1999;60:278–284
  70. Mueser KT, Torrey WC, Lynde D, Singer P, Drake RE. Implementing evidence-based practices for people with severe mental illness. Behavior Modification. 2003;27:387–411
  71. Murphy S. An experimental design for the development of adaptive treatment strategies. Statistics in Medicine. 2005;24:1455–1481
  72. National Institute on Alcohol Abuse and Alcoholism , National Institute on Drug Abuse , National Institute on Mental Health . Workshop. Methodology of conducting pharmacologic clinical trials in patients with alcohol/drug dependence and psychiatric comorbidity. 2006, February–March;Bethesda, MD
  73. New Freedom Commission on Mental Health . Achieving the promise: Transforming mental health care in America. Washington, DC: Department of Health and Human Services; 2003;
  74. Nuttbrock LA, Rahav M, Rivera JJ, Ng-Mak DS, Link BG. Outcomes of homeless mentally ill chemical abusers in community residences and a therapeutic community. Psychiatric Services. 1998;49:68–76
  75. Osher FC, Kofoed LL. Treatment of patients with psychiatric and psychoactive substance use disorders. Hospital and Community Psychiatry. 1989;40:1025–1030
  76. Petrakis IL, Nich C, Ralevski E. Psychotic spectrum disorders and alcohol abuse: A review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram. Schizophrenia Bulletin. 2006;32:644–654
  77. Petry NM. A comprehensive guide to the application of contingency management procedures in general clinical settings. Drug and Alcohol Dependence. 2000;58:9–25
  78. Ridgely MS, Goldman HH, Willenbring M. Barriers to the care of persons with dual diagnoses: Organizational and financing issues. Schizophrenia Bulletin. 1990;16:123–132
  79. Ridgely MS, Osher FC, Goldman H, Talbott JA. Executive summary: Chronic mentally ill young adults with substance abuse problems: A review of research, treatment, and training issues. Baltimore: The University of Maryland; 1987;
  80. Ries RK, Dyck DG, Short R, Srebnik D, Fisher A, Comtois KA. Outcomes of managing disability benefits among patients with substance dependence and severe mental illness. Psychiatric Services. 2004;55:445–447
  81. Sacks S, Sacks JY, McKendrick K, Banks SM, Stommel J. Modified therapeutic community for MICA offenders: Crime outcomes. Behavioral Sciences and the Law. 2004;22:477–501
  82. Shafer MS, Arthur B, Franczak MJ. An analysis of post-booking jail diversion programming for persons with co-occurring disorders. Behavioral Sciences and the Law. 2004;22:771–785
  83. Sigmon S, Steingard S, Badger GJ, Anthony SL, Higgins ST. Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: A feasibility study. Experimental and Clinical Psychopharmacology. 2000;8:509–517
  84. Simpson DD. Modeling treatment process and outcomes. Addiction. 2001;96:207–211
  85. Simpson DD, Joe GW, Rowan-Szal GA. Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence. 1997;47:227–235
  86. Steadman HJ, Naples M. Assessing the effectiveness of jail diversion programs for persons with serious mental illness and co-occurring substance use disorders. Behavioral Sciences and the Law. 2005;23:163–170
  87. Stein LI, Test MA. Alternatives to mental hospital treatment: Conceptual model, treatment program, and clinical evaluation. Archives of General Psychiatry. 1980;37:392–397
  88. In:  Stobo JD,  McGeary M,  Barnes DK editor. Improving the social security disability decision process: Final report. Washington, DC: The National Academies Press; 2006;
  89. Stroup S, Appelbaum P, Swartz MS, Patel M, Davis S, Jeste DV, et al. Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial. Schizophrenia Research. 2005;80:1–8
  90. Sullivan, C. J., McKendrick, K., Sacks, S., & Banks, S. (submitted). Modified therapeutic community treatment for offenders with MICA disorders: Substance use outcomes. Manuscript submitted for publication.
  91. Susser E, Valencia E, Conover S, Felix A, Tsai WY, Wyatt RJ. Preventing recurrent homelessness among mentally ill men: A “critical time” intervention after discharge from a shelter. American Journal of Public Health. 1997;87:256–262
  92. Swanson AJ, Pantalon MV, Cohen KR. Original interviewing and treatment adherence among psychiatric and dually diagnosed patients. Journal of Nervous and Mental Disease. 1999;187:630–635
  93. Timko C, Chen S, Sempel JM, Barnett P. Dual diagnosis patients in community or hospital care: One-year outcomes and health care utilization costs. Journal of Mental Health. 2006;15:163–177
  94. Timko C, Sempel JM. Intensity of acute services, self-help attendance and one-year outcomes among dual diagnosis patients. Journal on Studies of Alcohol. 2004;65:274–282
  95. Vaillant GE. Natural history of alcoholism revisited. 2nd ed. Cambridge, MA: Harvard University Press; 1995;
  96. Weiss RD, Griffin ML, Greenfield SF, Najavits LM, Wyner D, Soto JA, et al. Group therapy for patients with bipolar and substance dependence: Results of a pilot study. Journal of Clinical Psychiatry. 2000;61:361–367
  97. Weiss RD, Griffin ML, Kolodziej ME, Greenfield SF, Najavits LM, Daley DC, et al. A randomized trial of integrated group therapy versus group drug counseling for bipolar disorder and substance dependence. American Journal of Psychiatry. 2007, January;100–107
  98. Wells KB. Treatment research at the crossroads: The scientific interface of clinical trials and effectiveness research. American Journal of Psychiatry. 1999;156:5–10
  99. Xie H, Drake RE, McHugo GJ. Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group-based modeling approach. Administration and Policy in Mental Health & Mental Health Services Research. 2006;33:423–432
  100. Xie H, McHugo GJ, Helmstetter BS, Drake RE. Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders. Schizophrenia Research. 2005;75:337–348
  101. Ziedonis D, Trudeau K. Motivation to quit using substances among individuals with schizophrenia: Implications for a motivation-based treatment model. Schizophrenia Bulletin. 1997;23:229–238
  102. Ziedonis DM, Smelson D, Rosenthal RN, Batki SL, Green AI, Henry RJ, et al. Improving the care of individuals with schizophrenia and substance use disorders. Journal of Psychiatric Practice. 2005;11:315–339

PII: S0740-5472(07)00100-6

doi: 10.1016/j.jsat.2007.01.011

Journal of Substance Abuse Treatment
Volume 34, Issue 1 , Pages 123-138 , January 2008

Article Tools